Adolescent contraception

CMAJ. 2021 Aug 9;193(31):E1218. doi: 10.1503/cmaj.202413.

Authors

Margot A Rosenthal¹, Sarah K McQuillan²

Affiliations

¹ Department of Obstetrics, Gynecology and Reproductive Sciences (Rosenthal), University of Manitoba, Winnipeg, Man.; Department of Obstetrics and Gynecology (McQuillan), University of Calgary, Calgary, Alta. umrose32@myumanitoba.ca.
² Department of Obstetrics, Gynecology and Reproductive Sciences (Rosenthal), University of Manitoba, Winnipeg, Man.; Department of Obstetrics and Gynecology (McQuillan), University of Calgary, Calgary, Alta.

No abstract available

MeSH terms

Adolescent
Bone Density
Canada
Contraception / economics
Contraception / methods*
Contraceptive Agents, Female / therapeutic use
Desogestrel / therapeutic use
Female
Humans
Intrauterine Devices, Copper
Levonorgestrel / therapeutic use
Long-Acting Reversible Contraception / methods
Medroxyprogesterone Acetate / adverse effects
Medroxyprogesterone Acetate / therapeutic use
Pregnancy
Pregnancy, Unplanned
Sexually Transmitted Diseases / prevention & control

Substances

Contraceptive Agents, Female
etonogestrel
Levonorgestrel
Desogestrel
Medroxyprogesterone Acetate